Anika Therapeutics (ANIK) Other Non-Current Assets (2010 - 2026)

Anika Therapeutics (ANIK) has 17 years of Other Non-Current Assets data on file, last reported at $4.3 million in Q1 2026.

• On a quarterly basis, Other Non-Current Assets fell 24.84% year-over-year to $4.3 million in Q1 2026; TTM through Mar 2026 was $4.3 million, a 24.84% decrease from a year earlier, with the FY2025 full-year figure at $4.0 million, up 99.11% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $4.3 million, up from $4.0 million in the prior quarter.
• Over the last five years, Other Non-Current Assets for ANIK reached as high as $36.3 million in Q4 2023 and fell as low as $2.0 million in Q4 2024.
• Historically, Other Non-Current Assets has averaged $15.0 million across 5 years, with a median of $17.9 million in 2023.
• Across the five-year window, Other Non-Current Assets soared 110.84% in 2023 and sank 94.42% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $17.2 million in 2022, then jumped by 110.84% to $36.3 million in 2023, then sank by 94.42% to $2.0 million in 2024, then surged by 99.11% to $4.0 million in 2025, then advanced by 6.67% to $4.3 million in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $4.3 million in Q1 2026, $4.0 million in Q4 2025, and $5.6 million in Q2 2025.